News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
362,423 Results
Type
Article (20675)
Company Profile (128)
Press Release (341620)
Multimedia
Podcasts (73)
Webinars (11)
Section
Business (113337)
Career Advice (886)
Deals (20318)
Drug Delivery (97)
Drug Development (53035)
Employer Resources (79)
FDA (8383)
Job Trends (8039)
News (199048)
Policy (18566)
Tag
Academia (785)
Accelerated approval (3)
Adcomms (17)
Allergies (45)
Alliances (30788)
ALS (60)
Alzheimer's disease (692)
Antibody-drug conjugate (ADC) (98)
Approvals (8405)
Artificial intelligence (153)
Autoimmune disease (16)
Automation (6)
Bankruptcy (179)
Best Places to Work (5784)
BIOSECURE Act (13)
Biosimilars (100)
Biotechnology (58)
Bladder cancer (44)
Brain cancer (20)
Breast cancer (127)
Cancer (1191)
Cardiovascular disease (118)
Career advice (721)
Career pathing (21)
CAR-T (60)
Cell therapy (174)
Cervical cancer (5)
Clinical research (44600)
Collaboration (510)
Compensation (181)
Complete response letters (23)
COVID-19 (1190)
CRISPR (24)
C-suite (162)
Cystic fibrosis (62)
Data (1256)
Decentralized trials (2)
Denatured (18)
Depression (27)
Diabetes (151)
Diagnostics (2228)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (21)
Drug discovery (83)
Drug pricing (112)
Drug shortages (30)
Duchenne muscular dystrophy (63)
Earnings (42192)
Editorial (32)
Employer branding (10)
Employer resources (73)
Events (52051)
Executive appointments (482)
FDA (9065)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (348)
Gene editing (51)
Generative AI (18)
Gene therapy (160)
GLP-1 (610)
Government (1962)
Grass and pollen (4)
Guidances (28)
Healthcare (6436)
Huntington's disease (13)
IgA nephropathy (22)
Immunology and inflammation (88)
Indications (20)
Infectious disease (1275)
Inflammatory bowel disease (89)
Inflation Reduction Act (8)
Influenza (29)
Intellectual property (61)
Interviews (116)
IPO (8099)
IRA (45)
Job creations (2504)
Job search strategy (654)
Kidney cancer (7)
Labor market (24)
Layoffs (281)
Leadership (16)
Legal (4443)
Liver cancer (32)
Lung cancer (177)
Lymphoma (97)
Machine learning (3)
Management (30)
Manufacturing (232)
MASH (53)
Medical device (2886)
Medtech (2890)
Mergers & acquisitions (12524)
Metabolic disorders (521)
Multiple sclerosis (55)
NASH (20)
Neurodegenerative disease (55)
Neuropsychiatric disorders (23)
Neuroscience (1040)
NextGen: Class of 2025 (2456)
Non-profit (940)
Now hiring (22)
Obesity (323)
Opinion (191)
Ovarian cancer (35)
Pain (72)
Pancreatic cancer (40)
Parkinson's disease (92)
Partnered (11)
Patents (152)
Patient recruitment (58)
Peanut (16)
People (35136)
Pharmaceutical (74)
Pharmacy benefit managers (21)
Phase I (13941)
Phase II (18945)
Phase III (15083)
Pipeline (793)
Policy (127)
Postmarket research (1657)
Preclinical (4949)
Press Release (31)
Prostate cancer (67)
Psychedelics (16)
Radiopharmaceuticals (171)
Rare diseases (256)
Real estate (3409)
Recruiting (29)
Regulatory (13434)
Reports (24)
Research institute (850)
Resumes & cover letters (138)
Rett syndrome (1)
RNA editing (2)
RSV (25)
Schizophrenia (62)
Series A (64)
Series B (37)
Service/supplier (8)
Sickle cell disease (36)
Special edition (15)
Spinal muscular atrophy (111)
Sponsored (12)
Startups (2198)
State (2)
Stomach cancer (10)
Supply chain (55)
Tariffs (43)
The Weekly (53)
Vaccines (294)
Venture capitalists (29)
Weight loss (245)
Women's health (14)
Worklife (8)
Date
Today (102)
Last 7 days (458)
Last 30 days (1388)
Last 365 days (17714)
2025 (5830)
2024 (18814)
2023 (21039)
2022 (28348)
2021 (29272)
2020 (27266)
2019 (21479)
2018 (16666)
2017 (18569)
2016 (17506)
2015 (20333)
2014 (16098)
2013 (13763)
2012 (14773)
2011 (15092)
2010 (13837)
Location
Africa (427)
Alabama (23)
Alaska (1)
Arizona (68)
Arkansas (8)
Asia (33979)
Australia (4440)
California (2746)
Canada (1220)
China (402)
Colorado (104)
Connecticut (108)
Delaware (78)
Europe (56401)
Florida (467)
Georgia (58)
Idaho (16)
Illinois (263)
India (23)
Indiana (177)
Iowa (3)
Japan (141)
Kansas (67)
Kentucky (17)
Louisiana (3)
Maine (7)
Maryland (421)
Massachusetts (2324)
Michigan (49)
Minnesota (162)
Mississippi (1)
Missouri (30)
Montana (10)
Nebraska (11)
Nevada (18)
New Hampshire (8)
New Jersey (1104)
New Mexico (21)
New York (860)
North Carolina (544)
North Dakota (2)
Northern California (1167)
Ohio (83)
Oklahoma (5)
Oregon (22)
Pennsylvania (654)
Puerto Rico (12)
Rhode Island (18)
South America (653)
South Carolina (3)
Southern California (1117)
Tennessee (38)
Texas (362)
United States (11047)
Utah (65)
Virginia (89)
Washington D.C. (45)
Washington State (236)
Wisconsin (24)
362,423 Results for "medison pharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
April 28, 2025
·
3 min read
Job Trends
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
Medison Pharma and Alnylam Pharmaceuticals, Inc. announced a further expansion of their existing partnership in Central & Eastern Europe and Israel, to also include selected markets in LATAM and APAC and additional international markets.
April 30, 2024
·
5 min read
Press Releases
Kairos Pharma Ltd. Highlights Participation in Recent and Upcoming Scientific and Industry Events
March 28, 2025
·
3 min read
Press Releases
Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering
March 10, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
March 7, 2025
·
5 min read
Press Releases
Kairos Pharma Ltd. Announces Department of Defense Grant to Support Its Study of Lead Compound ENV105 to Prevent Drug Resistance in Lung Cancer
April 17, 2025
·
4 min read
Press Releases
Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.
March 26, 2025
·
10 min read
Business
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries
Medison Pharma announced their exclusive multi-national agreement with Regeneron Ireland DAC, a wholly owned subsidiary of Regeneron Pharmaceuticals, Inc., a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases, to commercialize Libtayo®, a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells, in select European markets and additional markets around the world.
January 8, 2024
·
5 min read
1 of 36,243
Next
